Chronic heart failure (CHF) is responsible for significant morbidity and mortality worldwide, 24 mainly as a result of neurohumoral activation. Acupuncture has been used to treat a wide 25 range of diseases and conditions. In this study, we investigated the effects of 26 electroacupuncture (EA) on the sympathetic nerve activity, heart function and remodeling in 27 CHF rats after ligation of the left anterior descending coronary artery. CHF rats were 28 randomly selected to EA and control groups for acute and chronic experiments. In the acute 29 experiment, both the renal sympathetic nerve activity (RSNA) and cardiac sympathetic 30 afferent reflex (CSAR) elicited by epicardial application of capsaicin were recorded. In the 31 chronic experiment, we performed EA for 30 minutes once a day for 1 week to test the 32 long-term EA effects on heart function , remodeling as well as infarct size in CHF rats. we demonstrated EA attenuates sympathetic overactivity. Additionally, long-term EA 39 improves cardiac function and remodeling and reduces infarct size in CHF rats. EA is a novel 40 and potentially useful therapy for treating CHF. 
Introduction 67
Chronic heart failure (CHF) is a serious, debilitating and increasingly prevalent condition 68 with a poor survival rate. CHF was originally considered to be a hemodynamic disorder, but 69 there is increasing evidence to indicate that CHF is characterized by overwhelmingly 70 compensatory neurohumoral activation including sympathetic overactivity (6, 20, 33, 44, 47) . 71 The renal sympathetic nerve activity poses significant contribution to the increased 72 sympathetic drive and altered neurohumoral responses in CHF (12). In addition, the 73 sympathetic overactivity is closely related to abnormalities in cardiovascular reflexes in 74 CHF. It is well known that enhanced cardiac sympathetic afferent reflex is contributory to 75 sustained higher sympathetic outflow activity in the CHF state (45, 46) . Prolonged increase of 76 sympathetic tone and withdrawal of parasympathetic activity have been associated with the 77 progression of heart failure, increased sudden death risk, and increased mortality (13, 38) . As 78 this has been proven to be detrimental, reduction of sympathetic overactivity has become the 79 cornerstone of CHF treatment. 80 In traditional Chinese medicine, acupuncture, including the more effective 81 electroacupuncture, has been used to treat a variety of diseases and disorders for at least a 82 thousand years and increasingly acupuncture is being accepted as an alternative medical 83 therapy worldwide. Both clinical evidence and animals studies indicate that acupuncture may 84 have therapeutic and modulatory effects on some types of hypertension, arrhythmias and 85 coronary heart disease (27, 31, 37, 52) . It has been demonstrated that EA could lower 86 (Beijing Sheng Da medical instrument center, Beijing, China) for 30 minutes throughout the 155 study. In order to exclude the effect of EA current, for the control EA used in the experiment, 156
Pianli-Wenliu acupoints [large intestine (LI) [6] [7] in the forelimb were selected because they 157 are near the neiguan-jianshi acupoint yet are located along another meridian (large intestine 158 meridian) (51). 159
Measurement of infarct size 160
The left ventricles were cut from apex to base into four transverse slices, which were 161 processed in a routine manner for histological study. Sections 5um thick were cut, stained 162 with Masson's trichrome stain. ImageJ 1.34 software was used to measure lengths and areas 163 of infarct and LV. In each slice, the infarct ratio was defined as the ratio of the length of the 164 endocardial circumference made up by the infarct area to the entire endocardial circumference. 165 Infarct area in each slice was calculated by multiplying the infarct ratio by the LV area of the 166 whole slice. Infarct ratio of the entire LV was obtained by calculating the ratio of the total 167 infarct area to the sum of LV areas in all slices analyzed (5, 36) . 168
Experiment protocol 169

Acute experiments 170
Acute experiments have been consisted of two cohorts. In the first cohort, three groups were 171 prepared for the acute experiments including CHF rats-EA (n=6), CHF rats-control EA (n=6) 172 and sham rats-EA (n=6). After the blood pressure, heart rate and baseline RSNA were stable 173 for at least 10mins during recording, we performed bilateral EA at neiguan and jianshi 174 acupoint in CHF and sham rats group at 2Hz and 2mA for 30mins. The control EA were 175 performed at same intensity for 30mins in the other CHF rats group. We tried to discernwhether the EA at the neiguan-jianshi acupoint could reduce the renal sympathetic nerve 177 activity among CHF rats compared with sham rats and control EA treated CHF rats. In second 178 cohort, three groups including CHF rats-EA (n=6), CHF rats-control EA (n=6) and sham 179 rats-EA (n=6) were used to record CSAR. After the blood pressure, heart rate and baseline 180 RSNA were stable for at least 10mins, the CSAR elicited by epicardial application of 181 capsaicin was recorded before and 30min after EA and control EA. We evaluated whether EA 182 at the neiguan-jianshi acupoint could weaken the CSAR among CHF rats compared with 183 sham rats and control EA treated CHF rats. 184
Chronic experiments 185
The rats were divided into three groups: CHF rats-EA (n=10), CHF rats-metoprolol (n=6), 186 CHF rats-control EA (n=7) as well as CHF rats without EA (n=6). In the chronic experiment, 187 EA was initiated 4 weeks after ligation of left anterior descending coronary artery. All rats 188
were treated under anesthesia when EA stimulation was given. We performed bilateral EA at 189 the neiguan-jianshi acupoint in CHF rats. Meanwhile, control EA were performed in another 190 CHF rats group using the Pianli-Wenliu acupoint. The stimulation was given at 2Hz and 2mA 191 for 30min once per day for a total duration of 1 week. After 1 week of stimulation, the cardiac 192 structure and function of rats within all groups was assessed by animal echocardiography 193 (Vevo 2100 Detector MS250, FUJIFILM VisualSonics, Inc. Toronto, Canada). For 194 comparison with the effects of EA on heart performance, the effective 1-selective blocker, 195 metoprolol (MP; Sigma, St.Louis, U.S.A.), was used as a control. The CHF rats orally 196 administered the metoprolol on the dose basis of 60mg/kg once per day for 7 days by direct 197 gastric lavage (42). After the examination of animal echocardiography, the CHF rats weresacrificed for heart excision,the ratio of heart weight to body weight and infarct size were 199
measured. 200
Statistical analysis 201
The effects Newman-Keuls test for post hoc analysis was used when multiple comparisons were made. 207
Other Comparisons were assessed by Student's paired t-test. All statistical analysis were done 208 using computer software (SPSS; Chicago, IL). All data were expressed as mean ± SE. A value 209 of P<0.05 was considered statistically significant. 210
Results
211
Effects of coronary ligation on baseline hemodynamics and heart weight 212
The measurements of cardiac function and mean arterial pressure (MAP) in sham rats (n=17) 213 and CHF rats (n=29) are shown in Table 1 . It is readily observed that the CHF rats have a 214 significant decrease in ejection fraction (EF) and fraction shortening (FS) as well as MAP 215 compared with sham groups (p<0.05). Additionally, left ventricular end-systolic dimension 216 (LVESD) and left ventricular end-diastolic dimension (LVEDD) were significantly enlarged 217 in CHF rats compared with sham rats (P<0.05). The table-1 also demonstrates that heart 218 weight and the ratio of heart weight to body weight were significantly greater in CHF group 219 rats than in sham group rats (P<0.05). Overall, this data indicates the presence of myocardial 220 damage and suggests a decreased contractile function and cardiac remodeling in CHF rats. 221
Effects of EA on renal sympathetic nerve activity (RSNA) and mean arterial pressure 222 (MAP) 223 A representative recording of effects of EA on RSNA and MAP is shown in Figure-1 . As can 224 be seen, EA significantly lowered the MAP and RSNA in CHF rats compared with sham rats 225 and control EA treated CHF rats. As shown in Figure-2 The representative recording of effects of EA on CSAR before-and-after EA is shown in 233
Figure-3, which demonstrates that there is significant inhibition of CSAR in CHF rats after 234 EA. Figure-4 demonstrates that RSNA and MAP responses to epicardial application of 235 capsaicin is significantly enhanced in CHF rats than in Sham rats before EA (P<0.05) 236
( Figure-4A and B) . After the treatment of EA, the increase in RSNA and MAP induced by 237 capsaicin among CHF rats were significantly inhibited compared with sham rats and control 238 EA treated CHF rats (P<0.05). The control EA had no significant effect on RSNA and MAP 239 by capsaicin in CHF rats. 1-selective blocker, metoprolol on heart function and structure. Additionally, Figure-6 shows 247 the EA could as well shrink the infarct size in CHF rats compared with non-EA treated CHF 248 rats (P<0.05), which is consistent with effects of metoprolol, but the effects of EA are weaker 249 than that of metoprolol in reducing the infarct size (P<0.05). However, there was no 250 significant difference in ratio of heart weight to body weight among EA treated CHF rats and 251 control EA treated CHF rats and CHF rats without treatment. 252
Discussion 253
Chronic heart failure originates from an impairment of the systolic and the diastolic functions 254 of the heart. The main causes of CHF today are ischemic heart disease and hypertension as 255 well as cardiomyopathy (11). Despite optimised heart failure medication, chronic heart failure 256 continues to cause significant morbidity and mortality rates worldwide, demonstrated by a 257 5-year survival rate of 25% in men and 38% in women (17), making it highly desirable to 258 discover another effective way to treat CHF. This paper is the first animal study to directly 259 examine the effects of EA on sympathetic activity and progression of CHF after left anterior 260 descending coronary artery ligation in CHF rats. We found direct evidence EA reduces the 261 renal sympathetic nerve activity and inhibit cardiac sympathetic afferent reflex which is 262 sensitized in the CHF state. Additionally, EA plays a potentially useful role in improving 263 cardiac function and remodeling and reducing infarct size. The main objective of the presentstudy was to test the hypothesis that EA can be beneficial to modulate sympathetic activity in 265 the CHF state and improve the function and structure of the debilitating CHF as well as 266 reducing the infarct size, which could be comparable to effects of the beta-blockade drugs like 267 metoprolol. We provide the evidence that EA could be usefully alternative way, at least in the 268 complementary way , to treat CHF. 269 The mechanisms underlying CHF are partially understood. Mounting evidence indicates 270 that neurohumoral activation, especially autonomic dysfunction including sympathetic 271 overactivity, contributes to the progression of CHF (23, 33, 44, 47) . In fact, sympathetic 272 activation is even present early in the course of left ventricular dysfunction (3, 14) . In an 273 animal model of early left ventricular dysfunction without overt heart failure, among which it 274 has shown that sympathetically influenced low-frequency heart rate variability was 275 significantly increased and parasympathetically mediated high-frequency variability was 276 significantly decreased (10). Initially, the increased sympathetic nervous system activity 277 during the early phase of CHF helps the heart compensate for deteriorating pumping function. 278 However, excessively sustained activation has a devastating impact on cardiac function and 279 remodeling and therefore, the maladaptive process is a key factor in the pathophysiology of 280 CHF (44). Increased sympathetic drive and reduced parasympathetic activity have been 281 highly relevant to both disease severity and the prognosis in CHF (6). Therefore, reduction of 282 sympathetic overactivity has become the cornerstone of CHF treatment. Most recent 283 strategies have focused on preventing organs from high sympathetic drive by reducing the 284 sympathetic overactivity such as -adrenergic blockers (9). 285 Sympathetic overactivity may also directly and indirectly exert adverse effects on thestructure and function of heart. Reportedly, increased norepinephrine release is relevant to the 287 development of left ventricular hypertrophy and exerts toxical effects on cardiac fibroblasts 288 and myocytes (39, 41). In addition, high level norepinephrine acts through the -adrenergic 289 pathway to stimulate apoptosis in adult rat ventricular myocytes in vitro (7) and basic studies have demonstrated that sympathoexcitation was relevant to blunted arterial 292 baroreceptor and cardiopulmonary receptor reflexes as well as enhanced cardiac afferent 293 sympathetic reflex which is a sympathoexcitatory reflex (46, 47). In the brainstem, rostral 294 ventrolateral medulla (rVLM) is well known as the regulation center of sympathetic activity 295 (8). The central abnormalities of regulation for sympathetic nervous system overactivity in 296 chronic heart failure have been reported to play a significant role (21). It is well established 297 that brain renin angiotensin system, oxidative stress, the dysfunction of nitrogen oxide 298 production in the rVLM contribute to the sympathoexcitation and enhanced cardiac afferent 299 sympathetic reflex in chronic heart failure (16, 45, 54) . Therefore, rVLM is a potentially 300 powerful therapeutic target to suppress the sympathetic overactivation. With the current 301 various therapeutic approaches utilizing -adrenergic blockers, the prognosis is still not good 302 enough and it is necessary to avoid the side effects of medication. From the available data, 303 conservative pharmacological therapy is likely to be insufficient. 304 Acupuncture as a therapeutic intervention is widely accepted and practiced in the United 305
States (2). Acupuncture can effectively treat postoperative and chemotherapy nausea and 306 vomiting as well as postoperative pain. Acupuncture can also be useful as an effective method 307 to treat other situations, such as addiction, headache, tennis elbow, myofascial pain,osteoarthritis, low back pain, and asthma. The Neiguan-jianshi acupoint is most effective 309 point to treat cardiovascular diseases (24, 27, 52) . In previous studies, EA at the 310 neiguan-jianshi could inhibit cardiovascular sympathoexcitatory pressor reflex responses 311 triggered by chemical, mechanical and electrical stimulation in rats (4, 28, 30, 51) . For 312 example, stimulation of the median nerve to mimic EA at the Neiguan acupoint diminishes 313 regional myocardial ischemia triggered by a sympathetically mediated increase in cardiac 314 oxygen demand in cats with the partial coronary artery occluded (28). However, the exact 315 effects of EA on CHF are still elusive, due to ambiguous outcomes reported by different 316 clinical studies. Therefore, in this paper, we tried to examine if EA could also attenuate the 317 renal sympathetic nerve activity and cardiac sympathetic afferent reflex and improve cardiac 318 function and remodeling in CHF rats. The present study confirms our hypothesis that EA 319 improves cardiac function and cardiac remodeling, reduces infarct size by inhibition of 320 sympathetic activity in CHF rats, but the exact mechanisms to explain these changes remain 321 unknown. In previous studies, it has been demonstrated that group III and IV afferent 322 pathways in the median nerves were activated during EA, which provide input to a number of 323 regions in the hypothalamus, midbrain, and brain stem that are associated with cardiovascular 324 regulated sympathetic activity (28, 29, 32, 43) . Specifically, resection of the median nerve 325 eliminated the therapeutic effect of EA at the Jianshi-Neiguan acupoint (53). From previous 326 available studies, EA at neiguan-jianshi could activiate -and -opioid receptors to inhibit 327 sympathetic activity, specifically receptors located in the rostral ventrolateral medulla (rVLM) 328 (4, 29, 53) . Additionally, EA can induce preproenkephalin mRNA expression in rVLM which 329 accounts for reductions in sympathetic outflow (25). EA could result in modulation of thenNOS activity in the hypothalamus to regulate sympathetic outflow in spontaneously 331 hypertensive rats (19). EA could also modulate cardiac autonomic imbalance by increasing 332 the cardiac vagal component of heart rate variability (15, 22) . There are studies reporting that 333 vagal nerve stimulation markedly improved the long-term survival of CHF rats through the 334 prevention of pumping failure and cardiac remodeling (26, 50) . These effects could explain 335 our finding that the cardiac function and remodeling as well as infarct size reduction in CHF 336 rats could be improved by long-term EA stimulation via the possibility of enhanced vagal 337 drive and inhibited sympathetic activity. 338
Clinical Implication and Study Limitations 339
This present study shows for the first time that EA attenuates renal sympathetic nerve activity 340 and cardiac sympathetic afferent reflex in CHF rats and suggests that EA improves cardiac 341 function and remodeling as well as reducing infarct size to prevent cardiac progression in 342 chronic heart failure rats, which may provide evidence that EA could be a useful alternative 343 treatment method to heart failure. In addition to CHF, the sympathetic activity reduction also 344 plays a pivotal role in the treatment of other diseases, such as diabetes and chronic renal 345 failure (40), so it is conceivable that EA is a potentially promising and valuable way to 346 manage the category of these disorders. In this study, the usefulness of EA as a 347 complementary or alternative therapy in animals has herein been established, but the relevant 348 mechanism has not been well addressed. Therefore, more large-scale, long-term trials of 349 research on its clinical efficacy as well as the underlying mechanisms of its effects need to be 350 further performed. 
